Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

A new assay developed by researchers at Johns Hopkins University can accurately count the cells that comprise the HIV reservoir- one of the biggest obstacles in curing the disease. The development of the assay could help researchers who are

Novodiag CarbaR+, a test for detecting carbapenemase-producing enterobacteriaceae (CPE) in just 80 minutes, has been issued CE Marking for an IVD. CPE are bacteria that are resistant to the carbapenem class of antibiotics, and early detectio

Day Zero Diagnostics (DZD) is seeking to develop a more effective way of detecting infectious disease using artificial intelligence and genome sequencing. The Boston-based company announced it has raised $8.6 million in its mission to furthe

Personal genetics specialist, 23andMe received a nod from FDA for a genetic health risk report on a hereditary colorectal cancer syndrome. FDAs nod for the Mountain View, CA-based companys MUTYH-Associated Polyposis Genetic Health Risk repor

A simple blood test could help detect whether a newly transplanted lung is being rejected by a patient, even when there arent any apparent signs of rejection. The donor-derived cell-free DNA test was developed by the National Institutes of H

Researchers in the Stanford lab of Stephen Quake are using single cell RNA sequencing (scRNA-seq) in an effort to provide insight into food allergies and the antibodies that cause them. The results from their research were recently published

Danaher today announced a 5 percent year-over-year increase in its fourth quarter revenues, beating the consensus Wall Street estimate. For the three months ended Dec. 31, 2018, the Washington-based conglomerate posted $5.36 billion in reven

MilliporeSigma and Roche announced today that they have renewed a global distribution agreement for certain reagents and qPCR products. The agreement covers the distribution of Roches biochemical reagents and Kapa Biosystems portfolios, and

The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of close to 14% during the period 2019-2023, driven mainly by the growing number of MAs and collaborations, and rising focus on next-generation product

Luminex Corporation (Austin, Texas, USA) has completed its previously announced acquisition of MilliporeSigmas (Burlington, MA, USA) flow cytometry portfolio. Luminex offers a wide range of solutions applicable in diverse markets, including